TOLERA: Tolerance Enhancement in RA
NCT04120831
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Rheumatoid Arthritis
Interventions
DRUG:
Abatacept Injection
Sponsor
University of Erlangen-Nürnberg Medical School